Harlan breed beagles for use in experiments. Help us close Harlan down
and bring about an end to all animal testing.
Harlan Laboratories is an international company who supply ‘research models’ for use in experiments. These ‘models’ are animals, including beagle dogs.
Harlan breed (or ‘produce’ – to use their own terminology) beagles in the United Kingdom. They also offer their clients the option of purchasing ‘surgically-modified’ animals. This means that some beagles undergo surgery on Harlan premises so they are experiment-ready before being transported to a client’s laboratory.
In essence, Harlan make beagles to order.
Save the Harlan Beagles is headed by a group of professional women who believe that breeding beagles for use in vivisection is morally reprehensible, and who understand that experiments on any non-human species – as claimed predictive for humans – perpetuates failed science which adversely affects human health.
- To close Harlan’s UK beagle breeding/donor sites AND
- End the scientifically-failed and cruel testing of human medicines on non- human animals.
OUR OBJECTIVES WILL BE ACHIEVED BY:
- Peacefully and progressively raising mainstream public awareness of the Harlan Beagles’ plight.
- Working to raise awareness of up-to-date science by helping cross-party MPs who support the new science-based campaign For Life On Earth (FLOE), and collaborating with their Parliamentary initiatives that focus on science illustrated by the leading medical experts against experiments on animals, as claimed predictive for human response. For more on STHB’s collaboration with science-based FLOE please visit this link
- Helping like minded advocates for Beagles with a view to helping raise the standard of scientific anti-vivisection in the wake of the failed 3Rs campaign, which has led to an all time high number of animals in laboratory experiments, as confirmed by Home Office figures published in July 2013.
Please join our campaign and help us expose the wholly misleading propaganda surrounding animal experiments that protects £multi-billion commercial interests and is delaying revolutionary advances in cures for human diseases and conditions that will save human lives.